In-hospital mortality and failure to rescue after cytoreductive nephrectomy
- PMID: 22981674
- DOI: 10.1016/j.eururo.2012.08.069
In-hospital mortality and failure to rescue after cytoreductive nephrectomy
Abstract
Background: The risk of in-hospital mortality after cytoreductive nephrectomy (CNT) is non-negligible and may vary widely according to various patient and hospital characteristics and clinical contexts.
Objective: To better elucidate the mechanisms underlying variability in operative mortality after CNT.
Design, setting, and patients: Using the US-based Nationwide Inpatient Sample registry, a weighted estimate of 16 285 patients with metastatic renal cell carcinoma (mRCC) treated with CNT between 1998 and 2007 was made retrospectively.
Outcome measurements and statistical analysis: Failure to rescue (FTR), defined as the number of deaths in patients who developed an adverse outcome during hospitalization. Univariable and multivariable logistic regression models were used.
Results: Of all 16 285 mRCC patients who underwent a CNT, 31% had an occurrence of one complication or more. The overall FTR rate was 5% and differed significantly according to age (≥ 75 yr vs <75 yr: 7.9% vs 4.3%) and comorbidities (≥ 3 vs 0: 7.7% vs 4.8%), as well as hospital bed size (small vs large: 7.2% vs 5.3%, all p ≤ 0.03). Patients who had an occurrence of infections (19.3%), cardiac- (15.7%), respiratory- (11.4%), or vascular-related complications (16.5%) had significantly higher FTR rates. It is noteworthy that increasing hospital volume and number of hospital beds also corresponded to lower rates of FTR after adjusting for other covariates.
Conclusions: Following CNT for mRCC, the occurrence of infections, cardiac-, respiratory-, or vascular-related complications resulted in higher FTR rates. Hospitals with greater number of beds and higher annual hospital volume had lower FTR rates, confirming the concepts that support FTR as an indicator for better quality of care following a high-risk surgical procedure.
Crown Copyright © 2012. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.Ann Surg Oncol. 2011 Oct;18(10):2988-96. doi: 10.1245/s10434-011-1715-2. Epub 2011 Apr 16. Ann Surg Oncol. 2011. PMID: 21499808
-
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.BJU Int. 2012 Sep;110(6 Pt B):E183-90. doi: 10.1111/j.1464-410X.2012.10936.x. Epub 2012 Feb 9. BJU Int. 2012. PMID: 22321256
-
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.BJU Int. 2012 Jun;109(12):1807-12. doi: 10.1111/j.1464-410X.2011.10569.x. Epub 2011 Sep 27. BJU Int. 2012. PMID: 21951647
-
Epidemiology of the high-risk population: perioperative risk and mortality after surgery.Curr Opin Crit Care. 2015 Aug;21(4):322-7. doi: 10.1097/MCC.0000000000000221. Curr Opin Crit Care. 2015. PMID: 26126130 Review.
-
Failure to rescue in the surgical patient: a review.Curr Opin Crit Care. 2019 Dec;25(6):706-711. doi: 10.1097/MCC.0000000000000667. Curr Opin Crit Care. 2019. PMID: 31567517 Review.
Cited by
-
Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate?Curr Urol Rep. 2021 Oct 16;22(11):54. doi: 10.1007/s11934-021-01073-7. Curr Urol Rep. 2021. PMID: 34654989 Review.
-
The role of open radical nephrectomy in contemporary management of renal cell carcinoma.Transl Androl Urol. 2020 Dec;9(6):3123-3139. doi: 10.21037/tau-19-327. Transl Androl Urol. 2020. PMID: 33457285 Free PMC article. Review.
-
Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma.Curr Oncol Rep. 2020 Mar 13;22(4):35. doi: 10.1007/s11912-020-0895-y. Curr Oncol Rep. 2020. PMID: 32170461 Review.
-
Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.Eur Urol. 2018 Sep;74(3):387-393. doi: 10.1016/j.eururo.2018.05.025. Epub 2018 Jun 5. Eur Urol. 2018. PMID: 29880274 Free PMC article.
-
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.World J Urol. 2017 Dec;35(12):1807-1816. doi: 10.1007/s00345-017-2072-y. Epub 2017 Jul 12. World J Urol. 2017. PMID: 28702843 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
